(Total Views: 483)
Posted On: 09/11/2019 8:51:42 AM
Post# of 72433
I could see a total B platform partnership coming. The PR yesterday included all the indications of B in it for a reason I believe. They mentioned recent partnering interactions and stated that B for ABSSSI, B-OM, and all of the B digestive platform (my words) are being looked as interest for defensin-based therapies intensifies. We already have partnered the lowest grossing part of our B platform. Anything beyond this is a win. IMO
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)